Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients
Purpose: To know the possible differences in the toxicity profile of triple therapy with telaprevir between monoinfected and coinfected patients. Method: A retrospective observational study (January 2012- November 2013) of patients with HCV genotype 1, both monoinfected and coinfected with HIV, wh...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2014-01-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/1143.pdf |